Xeno-Free Defined Conditions for Culture of Human Embryonic Stem Cells, Neural Stem Cells and Dopaminergic Neurons Derived from Them

被引:105
作者
Swistowski, Andrzej
Peng, Jun
Han, Yi
Swistowska, Anna Maria
Rao, Mahendra S.
Zeng, Xianmin
机构
[1] Buck Institute for Age Research, Novato, CA
关键词
PARKINSONS-DISEASE; UNDIFFERENTIATED GROWTH; SUBSTANTIA-NIGRA; SELF-RENEWAL; TRANSPLANTATION; SURVIVAL; LINES; RATS; DIFFERENTIATION; GRAFTS;
D O I
10.1371/journal.pone.0006233
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Human embryonic stem cells (hESCs) may provide an invaluable resource for regenerative medicine. To move hESCs towards the clinic it is important that cells with therapeutic potential be reproducibly generated under completely defined conditions. Methodology/Principal Findings: Here we report a four-step scalable process that is readily transferable to a Good Manufacture Practice (GMP) facility for the production of functional dopaminergic neurons from hESCs for potential clinical uses. We show that each of the steps (propagation of ESC -> generation of neural stem cells (NSC)-> induction of dopaminergic precursors -> maturation of dopaminergic neurons) could utilize xeno-free defined media and substrate, and that cells could be stored at intermediate stages in the process without losing their functional ability. Neurons generated by this process expressed midbrain and A9 dopaminergic markers and could be transplanted at an appropriate time point in development to survive after transplant. Conclusions/Significance: hESCs and NSCs can be maintained in xeno-free defined media for a prolonged period of time while retaining their ability to differentiate into authentic dopaminergic neurons. Our defined medium system provides a path to a scalable GMP-applicable process of generation of dopaminergic neurons from hESCs for therapeutic applications, and a ready source of large numbers of neurons for potential screening applications.
引用
收藏
页数:11
相关论文
共 30 条
[1]   Isolation and Production of Cells Suitable for Human Therapy: Challenges Ahead [J].
Ahrlund-Richter, Lars ;
De Luca, Michele ;
Marshak, Daniel R. ;
Munsie, Megan ;
Veiga, Anna ;
Rao, Mahendra .
CELL STEM CELL, 2009, 4 (01) :20-26
[2]   Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture [J].
Amit, M ;
Carpenter, MK ;
Inokuma, MS ;
Chiu, CP ;
Harris, CP ;
Waknitz, MA ;
Itskovitz-Eldor, J ;
Thomson, JA .
DEVELOPMENTAL BIOLOGY, 2000, 227 (02) :271-278
[3]   RE-INNERVATION OF THE DENERVATED STRIATUM BY SUBSTANTIA NIGRA TRANSPLANTS - FUNCTIONAL CONSEQUENCES AS REVEALED BY PHARMACOLOGICAL AND SENSORIMOTOR TESTING [J].
BJORKLUND, A ;
DUNNETT, SB ;
STENEVI, U ;
LEWIS, ME ;
IVERSEN, SD .
BRAIN RESEARCH, 1980, 199 (02) :307-333
[4]   Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model [J].
Björklund, LM ;
Sánchez-Pernaute, R ;
Chung, SM ;
Andersson, T ;
Chen, IYC ;
McNaught, KS ;
Brownell, AL ;
Jenkins, BG ;
Wahlestedt, C ;
Kim, KS ;
Isacson, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :2344-2349
[5]   Noggin Enhances Dopamine Neuron Production from Human Embryonic Stem Cells and Improves Behavioral Outcome After Transplantation into Parkinsonian Rats [J].
Chiba, Shunmei ;
Lee, Young Mook ;
Zhou, Wenbo ;
Freed, Curt R. .
STEM CELLS, 2008, 26 (11) :2810-2820
[6]   SURVIVAL OF IMPLANTED FETAL DOPAMINE CELLS AND NEUROLOGIC IMPROVEMENT 12 TO 46 MONTHS AFTER TRANSPLANTATION FOR PARKINSONS-DISEASE [J].
FREED, CR ;
BREEZE, RE ;
ROSENBERG, NL ;
SCHNECK, SA ;
KRIEK, E ;
QI, JX ;
LONE, T ;
ZHANG, YB ;
SNYDER, JA ;
WELLS, TH ;
RAMIG, LO ;
THOMPSON, L ;
MAZZIOTTA, JC ;
HUANG, SC ;
GRAFTON, ST ;
BROOKS, D ;
SAWLE, G ;
SCHROTER, G ;
ANSARI, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (22) :1549-1555
[7]   TRANSPLANTATION OF HUMAN FETAL DOPAMINE CELLS FOR PARKINSONS-DISEASE - RESULTS AT 1 YEAR [J].
FREED, CR ;
BREEZE, RE ;
ROSENBERG, NL ;
SCHNECK, SA ;
WELLS, TH ;
BARRETT, JN ;
GRAFTON, ST ;
HUANG, SC ;
EIDELBERG, D ;
ROTTENBERG, DA .
ARCHIVES OF NEUROLOGY, 1990, 47 (05) :505-512
[8]   RESTORATION OF DOPAMINERGIC FUNCTION BY GRAFTING OF FETAL-RAT SUBSTANTIA NIGRA TO THE CAUDATE-NUCLEUS - LONG-TERM BEHAVIORAL, BIOCHEMICAL, AND HISTOCHEMICAL-STUDIES [J].
FREED, WJ ;
PERLOW, MJ ;
KAROUM, F ;
SEIGER, A ;
OLSON, L ;
HOFFER, BJ ;
WYATT, RJ .
ANNALS OF NEUROLOGY, 1980, 8 (05) :510-519
[9]  
ILIC D, 2009, STEM CELLS DEV
[10]   Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease [J].
Kim, JH ;
Auerbach, JM ;
Rodríguez-Gómez, JA ;
Velasco, I ;
Gavin, D ;
Lumelsky, N ;
Lee, SH ;
Nguyen, J ;
Sánchez-Pernaute, R ;
Bankiewicz, K ;
McKay, R .
NATURE, 2002, 418 (6893) :50-56